 |  |
| ABX | ||
| 2,545.877 | ||
| 36.3330 | 0.0145% | |
| BISNIS-27 | ||
| 552.236 | ||
| 1.5620 | 0.0028% | |
| DBX | ||
| 4,210.156 | ||
| 40.2560 | 0.0097% | |
| ECONOMIC30 | ||
| 116.030 | ||
| 0.1040 | 0.0009% | |
| ESGQKEHATI | ||
| 127.579 | ||
| 0.2060 | 0.0016% | |
| ESGSKEHATI | ||
| 128.261 | ||
| 0.4590 | 0.0036% | |
| I-GRADE | ||
| 232.471 | ||
| 1.2800 | 0.0055% | |
| AUDRP | ||
| 11,086.840 | ||
| 37.8900 | 0.3429% | |
| EURRP | ||
| 19,446.450 | ||
| 69.2700 | 0.3575% | |
| JPYRP | ||
| 107.603 | ||
| 0.4573 | 0.4268% | |
| SINRP | ||
| 12,879.750 | ||
| 43.3200 | 0.3375% | |
| USDRP | ||
| 16,687.000 | ||
| 42.0000 | 0.2523% | |
Pil antivirus Molnupiravir berpotensi menjadi obat oral pertama untuk pasien COVID-19 di dunia setelah menunjukkan hasil positif dalam laporan sementara. Untuk penggunaan di Indonesia, Kementerian Kesehatan menunggu uji klinis fase ketiga selesai terlebih dulu.
